ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

RNVO Renovo Grp

15.625
0.00 (0.00%)
08 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Renovo Grp LSE:RNVO London Ordinary Share GB00B081NX89 ORD 10P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 15.625 - 0.00 01:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
0 0 N/A 0

Renovo Share Discussion Threads

Showing 8226 to 8248 of 9125 messages
Chat Pages: Latest  341  340  339  338  337  336  335  334  333  332  331  330  Older
DateSubjectAuthorDiscuss
16/2/2011
10:07
that don't make sense, if they did phase II trial on lover level skin damage they should have done the same for phase III.
madmonkflin
16/2/2011
08:45
My guess here is that it doesn't work on deep scare tissue post major opps but does on more minor scars and more minor skin complaints. This leaves open the possibillity of a cosmetics deal, which in itself has significant value to a company like J&J. This and cash will underwrite a value in excess of 50p. Not sure if it would need any/many more trials as it's safety isn't an issue and it seems proved in lower level skin damage.
waterloo01
16/2/2011
02:03
2bozmo - I will stick with panmure's 30P target myself.

Therefore, we reset our price target to
30p and re-iterate our Buy recommendation.

Panmure have a note out..
Renovo's phase III REVISE trial on lead product candidate Juvista failed to
meet any of its endpoints. The result was surprising and unexpected.
Although the press release and subsequent conference call failed to reveal any
detail, it would appear that the outcome was unequivocal and very clear. The
product does not appear to work. Be that as it may, net of assumed
liquidation costs the company has c20p per share of cash and a technology
value conservatively worth at least 10p. Therefore, we reset our price target to
30p and re-iterate our Buy recommendation. We downgrade our FY2011
forecasts by 32% and counter-intuitively increase our FY2012 forecasts by
32% as we expect the company to reduce its R&D investment in light of
Friday's outcome.

daytraders
16/2/2011
00:57
Just had a look at the article in the Lancey for phase II and all seemed to be working fine then. How have they managed to fu@k it up?
madmonkflin
16/2/2011
00:37
Anyone got links to the photos?
hemehem
15/2/2011
22:13
groundhog day, didnt this happen on p2 in 2oo8 and share price dropped from over 200p to 59p. they rectified and came out with good results and then into p3. nothing good came of p3 and now they will reevaluate and come out positive from this. shire are not throwing this into touch yet.
hangs2left
15/2/2011
21:42
If your hiding here Sir ........ time to come home !!!!;-(
squire007
15/2/2011
21:04
2boz , wow , must pile back in then , fact
ludl0w
15/2/2011
19:02
Sorry Guys and gals for posting..but...Whilst the trial has (alledgedly) failed, does that mean its the end, i would imagine that the results from the other stages will be compared and examined for correctness then set aside and compared to these failed trials, Ferguson has put his soul into this company and product and im sure they are taking to time to evaluate whats gone on, for me there is such a wide gap between the successful trial and the failed one that something has gone wrong and i doubt its the product, the guy aint thick and he and the BOD would not have put this up for trial if they felt there was risk of failure..Something isnt right here and im sure the BOD are trying to determine what that is..

Having a go at them isnt the way forward..giving them time to evaluate is..I aint that experienced (and didnt get in at the top) but buying has continued and the share price appears to have stablised today..Just give it time for them to let us know and the media what went wrong..Im certain that trials in the past have been messed up so whos to say this wasnt?..the product (From the photos) ive seen works and you dont go into funding from majors without proof even before final trails...Something is wrong...

N.B i think its quite sad that folks come on here be littling pis they have lost money and rubbing it in..You deserve to lose all your funds..The investment made not just by pis invested but the BOD was based on successful trials not fairy dust...

Gl to you genuine holders and hopefully the Prf will find out wat happened and how to put it right

bearhug2
15/2/2011
18:41
It is the shareholders who come out of this debacle - as one might say - bearing the scars.

The staff will all get generous pay-offs, the directors will do very well out of it all. All the creditors will be paid back in full...and of course HM Revenue and Customs will get every penny they're owed.

.......For shareholders though it's bathtime. Let us hope Professor Ferguson never, ever, gets to run another public company. His credibility,alas, is shot through.

sandbank
15/2/2011
17:35
Nomura announced yesterday new 17p target
2bozmo
15/2/2011
17:33
Just a tale.Went golfing in spain last week.Great week sunny weather and good golf courses.Checked Renvovo early friday morning. Played the last comp a singles one and won the cup.Filled it full of champers and had a great night.
Woke up sat morning.Checked mt portfolio
All I can say is enjoy life while you can you don't what will happen next day

vandyke2
15/2/2011
17:05
When do you think we'll get an update from Renovo? This week?
hemehem
15/2/2011
13:39
Momentum building here.Fortune favours the brave...but £44m in the bank also helps...
addict
15/2/2011
11:12
well loads of buying now and l2 very strong, was interesting as at one point both sales and buys were at 17p, talk about little spread, i think brokers target of 30p has made people realise there is value here whatever happens.
daytraders
15/2/2011
11:07
indeed - I think we will see over 20 before the week is out!
strangled69
15/2/2011
10:46
Shorters twitching here...
addict
15/2/2011
09:13
just pointing out that today is the 1st time were in plus territory since big fall, and L2 strong and alot of 50,000 buys keep going through.
daytraders
15/2/2011
08:36
oh and dont read anything into the charts above, LSE are still testing there new system, we closed 15.50 yesterday and opend at 16.5p, so up 4.8% so far today.
daytraders
15/2/2011
08:34
well big buying at close last night and more buying at open, and were up so far today, hopefully bottom is in.
daytraders
15/2/2011
08:28
Not the first Renovo drug to fail, has one ever succeeded? No. Hope it goes to wall just so we can see how much zero value is.
hedger123
15/2/2011
08:19
I am long!
strangled69
15/2/2011
08:19
Day - there are question marks at the end of point 4. Of course this has value!!!!
strangled69
Chat Pages: Latest  341  340  339  338  337  336  335  334  333  332  331  330  Older

Your Recent History

Delayed Upgrade Clock